Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROH-001 ophthalmic solution phase I single and multiple dose study
jRCT2051230128Phase 1Completed
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in None comparing ROH-001 with Placebo (2 arms). Primary endpoints: Safety and Pharmacokinetics. Started Dec 2023; status: completed.
02
Drugs
atropine
Beyond the preview
Go deeper on jRCT2051230128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051230128.